The angio suites market size has grown strongly in recent years. It will grow from $1.9 billion in 2025 to $2.04 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing burden of cardiovascular and peripheral vascular diseases, rising demand for minimally invasive interventional procedures, expansion of hospital investments in advanced imaging infrastructure, increasing availability of x-ray and ct angiography platforms, growth in utilization of cardiac and neuro-angiography procedures.
The angio suites market size is expected to see strong growth in the next few years. It will grow to $2.7 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to rising adoption of bi-plane and hybrid angio suite configurations, increasing integration of advanced imaging and navigation technologies, growth in outpatient and ambulatory interventional care models, expanding penetration of oncology and peripheral vascular interventions, increasing healthcare infrastructure development in emerging markets. Major trends in the forecast period include increasing deployment of hybrid angio suites to support complex multi-disciplinary interventional procedures, rising adoption of minimally invasive image-guided vascular and neuro-interventional therapies, growing preference for bi-plane systems to improve visualization accuracy and procedure efficiency, expanding integration of radiation dose-optimization and patient safety features in angio environments, increasing establishment of dedicated interventional radiology units across hospitals and specialty centers.
The increasing incidence of cardiovascular disease is anticipated to drive the growth of the angio suites market in the coming years. Cardiovascular disease includes a wide range of conditions affecting the heart and blood vessels, such as coronary artery disease, heart attacks, strokes, and hypertension. Factors including sedentary lifestyles, unhealthy dietary habits, and rising obesity rates significantly contribute to the growing burden of cardiovascular disorders. Angio suites offer advanced imaging and interventional capabilities that enable accurate diagnosis and effective treatment of complex cardiovascular conditions through real-time visualization and minimally invasive procedures. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, deaths attributed to cardiovascular diseases reached 931,578, reflecting an increase of fewer than 3,000 deaths compared with 928,741 in 2023. In addition, the age-adjusted cardiovascular disease mortality rate rose to 233.3 per 100,000 population, representing a 4% increase from 224.4 per 100,000 in the previous year. As a result, the rising prevalence of cardiovascular disease is supporting the growth of the angio suites market.
Companies operating in the angio suites market are increasingly integrating advanced imaging technologies, such as biplane angiography systems, to improve diagnostic precision, enhance procedural efficiency, and deliver comprehensive visualization for complex vascular interventions. A biplane angiography system captures two perpendicular X-ray images simultaneously, providing real-time, high-resolution 2D and 3D visualization that supports precise device navigation and reduces procedure duration. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, introduced the Azurion Neuro Biplane system. This system combines enhanced 2D and 3D imaging with flexible C-arm rotation and angulation, extensive table-side controls, automatic beam rotation for properly oriented images, and Neuro Suite software integrated with ClarityIQ low-dose imaging, enabling faster diagnosis and treatment of stroke and other neurovascular conditions.
In September 2025, Siemens Healthineers AG, a Germany-based medical technology company, partnered with Interventional Systems to co-market the Micromate robotic system for use in angiography suites. The collaboration is designed to expand the adoption of the Micromate robot by integrating it with Siemens’ Artis range of C-arm scanners for interventional percutaneous procedures. The partnership focuses on accelerating procedure times, improving care quality, increasing accuracy, and reducing radiation exposure for both patients and operating room staff. Interventional Systems is a US-based medical robotics company specializing in miniature robotic devices developed for image-guided and needle-based procedures in angio suites and interventional radiology.
Major companies operating in the angio suites market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi Ltd, Mindray Medical International Limited, United Imaging Healthcare, Ziehm Imaging GmbH, Omega Medical Imaging, NeuroLogica Corporation, Terumo Corporation, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, AngioDynamics Inc, Microport Scientific Corporation, Biotronik, Asahi Intecc Co Ltd, Merit Medical Systems Inc.
North America was the largest region in the angio suites market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angio suites market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angio suites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the angio suites market by increasing import costs for imaging components, C-arm systems, detector panels, and precision electronic assemblies sourced through global supply chains, leading to higher capital expenditure for hospitals, ambulatory centers, and diagnostic imaging facilities. The impact is more significant across Asia-Pacific, Middle East, and Latin American regions that depend on equipment imports from North America and Europe, particularly within bi-plane and hybrid angio system segments. At the same time, tariffs are encouraging localization of manufacturing, regional assembly programs, and supplier diversification, which can support supply-chain resilience and gradual cost stabilization over the long term.
The angio suites market research report is one of a series of new reports that provides angio suites market statistics, including angio suites industry global market size, regional shares, competitors with a angio suites market share, detailed angio suites market segments, market trends and opportunities, and any further data you may need to thrive in the angio suites industry. This angio suites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An angio suite is a specialized facility within a hospital or clinic designed for performing minimally invasive, image-guided procedures, particularly those involving the vascular system (blood vessels). The term "angio" refers to blood vessels, while "suite" denotes the equipped room or area where these procedures are conducted. The primary goal of an angio suite is to offer a controlled environment for interventional radiology procedures.
Angio suites are typically categorized into single-plane and bi-plane types. Single-plane angio suites are equipped with imaging systems that capture images from a single angle, making them suitable for straightforward procedures and diagnostics. The technology in these suites includes X-ray angiography, computed tomography (CT) angiography, magnetic resonance angiography (MRA), and other imaging modalities. Applications of angio suites encompass cardiac angiography, neurology angiography, oncology angiography, peripheral vascular angiography, and more. These suites are utilized by hospitals, ambulatory surgical centers, diagnostic imaging centers, and other healthcare facilities.
The angio suites market consists of revenues earned by entities by providing services such as installation, maintenance, and servicing of angiography equipment, as well as the training and support provided to healthcare professionals using these system. The market value includes the value of related goods sold by the service provider or included within the service offering. The angio suites market also includes sales of sales of angiography systems, 3D imaging systems, image fusion systems, and radiation protection equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The angio suites market size is expected to see strong growth in the next few years. It will grow to $2.7 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to rising adoption of bi-plane and hybrid angio suite configurations, increasing integration of advanced imaging and navigation technologies, growth in outpatient and ambulatory interventional care models, expanding penetration of oncology and peripheral vascular interventions, increasing healthcare infrastructure development in emerging markets. Major trends in the forecast period include increasing deployment of hybrid angio suites to support complex multi-disciplinary interventional procedures, rising adoption of minimally invasive image-guided vascular and neuro-interventional therapies, growing preference for bi-plane systems to improve visualization accuracy and procedure efficiency, expanding integration of radiation dose-optimization and patient safety features in angio environments, increasing establishment of dedicated interventional radiology units across hospitals and specialty centers.
The increasing incidence of cardiovascular disease is anticipated to drive the growth of the angio suites market in the coming years. Cardiovascular disease includes a wide range of conditions affecting the heart and blood vessels, such as coronary artery disease, heart attacks, strokes, and hypertension. Factors including sedentary lifestyles, unhealthy dietary habits, and rising obesity rates significantly contribute to the growing burden of cardiovascular disorders. Angio suites offer advanced imaging and interventional capabilities that enable accurate diagnosis and effective treatment of complex cardiovascular conditions through real-time visualization and minimally invasive procedures. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, deaths attributed to cardiovascular diseases reached 931,578, reflecting an increase of fewer than 3,000 deaths compared with 928,741 in 2023. In addition, the age-adjusted cardiovascular disease mortality rate rose to 233.3 per 100,000 population, representing a 4% increase from 224.4 per 100,000 in the previous year. As a result, the rising prevalence of cardiovascular disease is supporting the growth of the angio suites market.
Companies operating in the angio suites market are increasingly integrating advanced imaging technologies, such as biplane angiography systems, to improve diagnostic precision, enhance procedural efficiency, and deliver comprehensive visualization for complex vascular interventions. A biplane angiography system captures two perpendicular X-ray images simultaneously, providing real-time, high-resolution 2D and 3D visualization that supports precise device navigation and reduces procedure duration. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, introduced the Azurion Neuro Biplane system. This system combines enhanced 2D and 3D imaging with flexible C-arm rotation and angulation, extensive table-side controls, automatic beam rotation for properly oriented images, and Neuro Suite software integrated with ClarityIQ low-dose imaging, enabling faster diagnosis and treatment of stroke and other neurovascular conditions.
In September 2025, Siemens Healthineers AG, a Germany-based medical technology company, partnered with Interventional Systems to co-market the Micromate robotic system for use in angiography suites. The collaboration is designed to expand the adoption of the Micromate robot by integrating it with Siemens’ Artis range of C-arm scanners for interventional percutaneous procedures. The partnership focuses on accelerating procedure times, improving care quality, increasing accuracy, and reducing radiation exposure for both patients and operating room staff. Interventional Systems is a US-based medical robotics company specializing in miniature robotic devices developed for image-guided and needle-based procedures in angio suites and interventional radiology.
Major companies operating in the angio suites market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi Ltd, Mindray Medical International Limited, United Imaging Healthcare, Ziehm Imaging GmbH, Omega Medical Imaging, NeuroLogica Corporation, Terumo Corporation, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, AngioDynamics Inc, Microport Scientific Corporation, Biotronik, Asahi Intecc Co Ltd, Merit Medical Systems Inc.
North America was the largest region in the angio suites market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angio suites market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the angio suites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the angio suites market by increasing import costs for imaging components, C-arm systems, detector panels, and precision electronic assemblies sourced through global supply chains, leading to higher capital expenditure for hospitals, ambulatory centers, and diagnostic imaging facilities. The impact is more significant across Asia-Pacific, Middle East, and Latin American regions that depend on equipment imports from North America and Europe, particularly within bi-plane and hybrid angio system segments. At the same time, tariffs are encouraging localization of manufacturing, regional assembly programs, and supplier diversification, which can support supply-chain resilience and gradual cost stabilization over the long term.
The angio suites market research report is one of a series of new reports that provides angio suites market statistics, including angio suites industry global market size, regional shares, competitors with a angio suites market share, detailed angio suites market segments, market trends and opportunities, and any further data you may need to thrive in the angio suites industry. This angio suites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An angio suite is a specialized facility within a hospital or clinic designed for performing minimally invasive, image-guided procedures, particularly those involving the vascular system (blood vessels). The term "angio" refers to blood vessels, while "suite" denotes the equipped room or area where these procedures are conducted. The primary goal of an angio suite is to offer a controlled environment for interventional radiology procedures.
Angio suites are typically categorized into single-plane and bi-plane types. Single-plane angio suites are equipped with imaging systems that capture images from a single angle, making them suitable for straightforward procedures and diagnostics. The technology in these suites includes X-ray angiography, computed tomography (CT) angiography, magnetic resonance angiography (MRA), and other imaging modalities. Applications of angio suites encompass cardiac angiography, neurology angiography, oncology angiography, peripheral vascular angiography, and more. These suites are utilized by hospitals, ambulatory surgical centers, diagnostic imaging centers, and other healthcare facilities.
The angio suites market consists of revenues earned by entities by providing services such as installation, maintenance, and servicing of angiography equipment, as well as the training and support provided to healthcare professionals using these system. The market value includes the value of related goods sold by the service provider or included within the service offering. The angio suites market also includes sales of sales of angiography systems, 3D imaging systems, image fusion systems, and radiation protection equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Angio Suites Market Characteristics
3. Angio Suites Market Supply Chain Analysis
4. Global Angio Suites Market Trends and Strategies
5. Angio Suites Market Analysis of End Use Industries
7. Global Angio Suites Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Angio Suites Total Addressable Market (TAM) Analysis for the Market
9. Angio Suites Market Segmentation
10. Angio Suites Market Regional and Country Analysis
11. Asia-Pacific Angio Suites Market
12. China Angio Suites Market
13. India Angio Suites Market
14. Japan Angio Suites Market
15. Australia Angio Suites Market
16. Indonesia Angio Suites Market
17. South Korea Angio Suites Market
18. Taiwan Angio Suites Market
19. South East Asia Angio Suites Market
20. Western Europe Angio Suites Market
21. UK Angio Suites Market
22. Germany Angio Suites Market
23. France Angio Suites Market
24. Italy Angio Suites Market
25. Spain Angio Suites Market
26. Eastern Europe Angio Suites Market
27. Russia Angio Suites Market
28. North America Angio Suites Market
29. USA Angio Suites Market
30. Canada Angio Suites Market
31. South America Angio Suites Market
32. Brazil Angio Suites Market
33. Middle East Angio Suites Market
34. Africa Angio Suites Market
36. Angio Suites Market Competitive Landscape and Company Profiles
37. Angio Suites Market Other Major and Innovative Companies
40. Angio Suites Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Angio Suites Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses angio suites market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for angio suites? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The angio suites market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Single-Plane; Bi-Plane2) By Technology: X-ray Angiography; Computed Tomography (CT) Angiography; Magnetic Resonance Angiography (MRA); Other Technologies
3) By Application: Cardiac Angiography; Neurology Angiography; Oncology Angiography; Peripheral Vascular Angiography; Other Applications
4) By End-User: Hospitals; Ambulatory Surgical Centers; Diagnostic Imaging Centers; Other End-Users
Subsegments:
1) By Single-Plane: Fixed C-arm Single-Plane Systems; Rotating C-arm Single-Plane Systems; Compact Single-Plane Systems2) By Bi-Plane: Fixed C-arm Bi-Plane Systems; Rotating C-arm Bi-Plane Systems; Hybrid Bi-Plane Systems
Companies Mentioned: Siemens Healthineers AG; GE Healthcare; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Shimadzu Corporation; Hitachi Ltd; Mindray Medical International Limited; United Imaging Healthcare; Ziehm Imaging GmbH; Omega Medical Imaging; NeuroLogica Corporation; Terumo Corporation; Boston Scientific Corporation; Medtronic plc; Abbott Laboratories; AngioDynamics Inc; Microport Scientific Corporation; Biotronik; Asahi Intecc Co Ltd; Merit Medical Systems Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Angio Suites market report include:- Siemens Healthineers AG
- GE Healthcare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Shimadzu Corporation
- Hitachi Ltd
- Mindray Medical International Limited
- United Imaging Healthcare
- Ziehm Imaging GmbH
- Omega Medical Imaging
- NeuroLogica Corporation
- Terumo Corporation
- Boston Scientific Corporation
- Medtronic plc
- Abbott Laboratories
- AngioDynamics Inc
- Microport Scientific Corporation
- Biotronik
- Asahi Intecc Co Ltd
- Merit Medical Systems Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.04 Billion |
| Forecasted Market Value ( USD | $ 2.7 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
